Manufacturing depression (63 page)

Holmes, J. “All You Need Is Cognitive Behaviour Therapy?”
British Medical Journal
324 (2002): 290.

Holmes, O. W. “Currents and Countercurrents in Medical Science.” In
Medical Essays 1842–1882
, 93–110. N.p.: Plain Label Books, n.d.

Horwitz, A. V., and J. C. Wakefield.
The Loss of Sadness.
Oxford: Oxford University Press, 2007.

Hume, S. “Prozac Getting a New Prescription: Burnett Tries Varied Approaches in Bringing Antidepressants to TV.”
Adweek
, Sept. 21, 1998.

Hunt, Charles. “Interaction of Detailing and Journal Advertising: How Detailing and Journal Advertising Impact New Prescriptions.” Rx PromoROI website, 2005. Available online at
www.rxpromoroi.org/pdf/interaction_whitepaper.pdf
.

“If the individual is depressed...” Advertisement.
American Journal of Psychiatry
101 (1945): xiii.

Impastatao, D. “The Story of the First Electroshock Treatment.”
American Journal of Psychiatry
116 (1960): 1113–14.

Insel, T. R., and R. Quirion. “Psychiatry as a Clinical Neuroscience Discipline.”
Journal of the American Medical Association
294, no. 17 (2005): 2221–24.

Jackson, S.
Melancholia & Depression: From Hippocratic Times to Modern Times.
New Haven: Yale University Press, 1990.

Jacobson, N. S., K. S. Dobson, P. A. Truax, M. E. Addis, K. Koerner, J. K. Gollan, E. Gortner, and S. E. Prince. “A Component Analysis of Cognitive-Behavior
Treatment for Depression.”
Journal of Consulting and Clinical Psychology
64 (1996): 295–304.

James Lind Library website, The Royal College of Physicians of Edinburgh. Available online at
www.jameslindlibrary.org
.

James, William.
The Varieties of Religious Experience.
Cambridge, MA: Harvard University Press, 1985.

Jellinek, E.
The Disease Concept of Alcoholism.
Piscataway, NJ: Alcohol Research Documentation, 1960.

Jessner, L., and V. G. Ryan.
Shock Treatment in Psychiatry.
New York: Grune & Stratton, 1941.

Jouanna, J.
Hippocrates.
Baltimore, MD: Johns Hopkins University Press, 1999.

Kalia, M., J. P. O’Callaghan, D. B. Miller, and M. Kramer, “Comparative Study of Fluoxetine, Sibutramine, Sertraline and Dexfenfluramine on the Morphology of Serotonergic Nerve Terminals Using Serotonin Immunohistochemistry.”
Brain Research
859, no. 1 (2000), 92–105.

Kalinowsky, L., and P. Hoch.
Shock Treatments and Other Somatic Procedures in Psychiatry.
New York: Grune & Stratton, 1946.

Kandel, E. R. “The New Science of Mind.” In
Best of the Brain from Scientific American
, edited by F. E. Bloom, 66–75. New York: Dana Press, 2007.

Kaptchuk, T. “Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine.”
Bulletin of the History of Medicine
72, no. 3 (1998): 389–433.

Katz, M. M., J. O. Cole, and H. A. Lowery. “Studies of the Diagnostic Process: The Influence of Symptom Perception, Past Experience and Ethnic Background on Diagnostic Decisions.”
American Journal of Psychiatry
125, no. 7 (1969): 937–47.

Kefauver, E.
In the Hands of a Few: Monopoly Power in America.
New York: Pantheon, 1965.

Kennedy, A. “Critical Review: The Treatment of Mental Disorders by Induced Convulsions.”
Journal of Neurology and Psychiatry
3 (1950): 49–82.

Kessler, R. C., S. Z. Hao, D. G. Blazer, and M. Swartz. “Prevalence, Correlates, and Course of Minor Depression and Major Depression in the National Comorbidity Survey.”
Journal of Affective Disorders
45 (1997): 19–30.

Kessler, R. C., K. R. Merikangas, P. Berglund, W. W. Eaton, D. S. Koretz, and E. E. Walters. “Mild Disorders Should Not Be Eliminated from the DSM-V.”
Archives of General Psychiatry
60 (2003): 1117–22.

Kessler, R. C., P. Berglund, O. Demler, R. Jin, D. Koretz, K. R. Merikangas, A. J. Rush, E. E. Walters, and P. S. Wang. “The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R).”
JAMA
289, no. 23 (2003): 3095–3105.

“Ketamine.”
Erowid
(“earth wisdom”) website, Erowid.org. Available online at
www.erowid.org/ketamine/
.

Kirk, S. A., and H. Kutchins.
The Selling of DSM: The Rhetoric of Science in Psychiatry.
New Brunswick, NJ: Aldine Transactions, 2008 (originally published 1992).

Kirsch, Irving, Thomas J. Moore, Alan Scoboria, and Sarah S. Nicholls. “The Emperor’s New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration.”
Prevention & Treatment
, July 2002. Available online at
http://journals.apa.org/prevention/volume5/pre0050023a.html
.

Kirsch, I., B. J. Deacon, T. B. Huedo-Medina, A. Scoboria, T. J. Moore, and B. T. Johnson. “Initial Severity and Antidepressant Benefits: A Meta-analysis of Data Submitted to the Food and Drug Administration.”
PloS Medicine
5, no. 2 (2008): 260–68.

Klein, D. F. “Preventing Hung Juries about Therapy Studies.”
Journal of Clinical and Consulting Psychology
64 (1996): 81–87.

Klerman, G. L. “The Patient’s Right to Effective Treatment: Implications of
Osheroff v. Chestnut Lodge.
”
American Journal of Psychiatry
147, no. 4 (1990): 410–11.

———. “Psychotropic Hedonism vs. Pharmacological Calvinism.”
The Hastings Center Report
2, no. 4 (1972): 1–3.

Klerman, G. L., G. E. Vaillant, R. L. Spitzer, and R. Michels. “A Debate on DSM-III.”
American Journal of Psychiatry
141 (1984): 539–55.

Kline, N.
From Sad to Glad: Kline on Depression.
New York: Ballantine, 1974.

———.“Monoamine Oxidase Inhibitors.” In
Discoveries in Biological Psychology
, edited by F. J. Ayd and B. Blackwell, 194–204. Philadelphia: J. B. Lippincott, 1970.

———. “Use of
Rauwolfia serpentina
Benth. in Neuropsychiatric Conditions.”
Annals of the New York Academy of Sciences
59 (1954): 107–32.

Knightley, P., H. Evans, E. Potter, et al.
Suffer the Children: The Story of Thalidomide.
New York: Viking, 1979.

Knoff, W. F. “A History of the Concept of Neurosis, with a Memoir of William Cullen.”
American Journal of Psychiatry
127 (1970): 80–84.

Kovel, J.
The Age of Desire: Case Histories of a Radical Psychoanalyst.
Boston: Beacon Books, 1981.

Kraepelin, E.
Lectures on Clinical Psychiatry.
New York: Hafner, 1968.

———. “Manifestations of Insanity.”
History of Psychiatry
3, no. 12 (1992): 509–29.

Kraepelin, E., and A. R. Diefendorf.
Clinical Psychiatry: A Text-Book for Students and Physicians.
London: Macmillan, 1912.

Kramer, P. D.
Against Depression.
New York: Viking, 2005.

———.
Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self.
New York: Penguin, 1994.

———. “The Valorization of Sadness: Alienation and the Melancholic Temperament.” In
Prozac as a Way of Life
, edited by C. Elliott and T. Chambers, 52. Chapel Hill, NC: University of North Carolina Press, 2004.

Kramer, S.
History Begins at Sumer: Thirty-Nine Firsts in Recorded History.
Philadelphia: University of Pennsylvania, 1988.

Kravitz, R. L., R. M. Epstein, M. D. Feldman, C. E. Franz, R. Azari, M. S. Wilkes, L. Hinton, and P. Franks. “Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial.”
JAMA
293, no. 16 (2005): 1995–2002.

Krishnan, V., and E. J. Nestler. “The Molecular Neurobiology of Depression.”
Nature
455 (2008): 894–902.

Kuhn, R. “The Imipramine Story.” In
Discoveries in Biological Psychiatry
, edited by F. J. Ayd and B. Blackwell, 205–17. Philadelphia: J. B. Lippincott, 1970.

———. “The Treatment of Depressive States with G22355 (Imipramine Hydrochloride).”
American Journal of Psychiatry
115 (1958): 459–64.

Kupfer, D. J., M. B. First, and D. A. Regier.
A Research Agenda for DSM-V.
Washington, DC: American Psychiatric Association, 2002.

Lacasse, J. R., and J. Leo. “Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature.”
PloS Medicine
2, no. 12 (2005): e392.

Laing, R. D.
The Divided Self: An Existential Study in Sanity and Madness.
Harmondsworth: Penguin, 1960.

La Mettrie, J. O. de. “Machine Man.” In
La Mettrie: Machine Man and Other Writings
, edited by A. Thomson. Cambridge: Cambridge University Press, 1996.

———. “Man a Machine (
Homme-machine
).” In
Man a Machine
(Homme-machine),
edited by Gertrude Carman Bussey. La Salle, IL: Open Court, 1912.

———. “Treatise on the Soul.” In
La Mettrie: Machine Man and Other Writings
, edited by A. Thomson. Cambridge: Cambridge University Press, 1996.

Langreth, R. “Mending the Mind. High Anxiety: Rivals Threaten Prozac’s Reign.”
Wall Street Journal
, May 9, 1996, p. B1.

Larkin, Philip.
High Windows.
New York: Farrar, Straus and Giroux, 1984.

Lasagna, L. “Congress, the FDA, and New Drug Development: before and after 1962.”
Perspectives in Biology and Medicine
32, no. 3 (1989): 322–43.

———. “The Controlled Clinical Trial: Theory and Practice.”
Journal of Chronic Diseases
1, no. 4 (1955): 353–67.

Laurence, W. L. “Drug Called a Psychic Energizer Found Useful in Treating Mental Illnesses.”
New York Times
, Science in review, December 22, 1957.

———. “Psychiatrist Hits Misuse of Shocks.”
New York Times
, August 21, 1953.

———. “Wide New Fields Seen for TB Drug Including Aid to Narcotics Addicts.”
New York Times
, July 5, 1952, pp. 1, 3.

Lears, T. J. J. “From Salvation to Self-Realization: Advertising and the Therapeutic Roots of the Consumer Culture.” In
The Culture of Consumption: Critical Essays in American History, 1880–1980
, edited by R. Fox and T. J. J. Lears, 1–30. New York: Pantheon, 1983.

Leber, P. “Approvable Action on Forrest Laboratories, Inc., NDA 20–822 Celexa (Citalopram HBr) for the Management of Depression.” Memorandum, Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, May 4, 1998.

LeVay, S.
Queer Science: The Use and Abuse of Research into Homosexuality.
Cambridge, MA: MIT Press, 1996.

Levine, H. G.,. “The Discovery of Addiction: Changing Conceptions of Habitual Drunkenness in America.”
Journal of Studies on Alcohol
39, no. 1 (1978): 144–51.

Lidz, T. “Adolf Meyer and the Development of American Psychiatry.”
American Journal of Psychiatry
123, no. 3 (Sept. 1966): 320–32.

Liebnau, J.
Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry.
Baltimore: Johns Hopkins University Press, 1987.